产品编号 :
Cas No. :
CAS No. |
1147-56-4 |
|---|---|
中文名称 |
1-(噻唑-2-基偶氮)-2-萘酚 |
英文名称 |
1-(thiazol-2-yldiazenyl)naphthalen-2-ol |
别名 |
GCBAKGGJQPMJLL-NTCAYCPXSA- | 2-Naphthalenol,1-[2-(2-thiazolyl)diazenyl]- | Acide bromebrique | (1Z)-1-(2-thiazolylhydrazinylidene)-2-naphthalenone | 1-(1,3-thiazol-2-yldiazenyl)naphthalen-2-ol | 1-(2-Thiazolylazo)-2-naphthol | AKOS015912775 | EINECS 214-5 |
标准英文名 |
1-(thiazol-2-yldiazenyl)naphthalen-2-ol |
MDL No. |
MFCD00021611 |
分子式 |
C13H9N3OS |
分子量 |
255.30 |
精确分子量 |
255.05 |
SMILES |
OC1=CC=C2C=CC=CC2=C1N=NC1=NC=CS1 |
标准SMILES |
OC1=CC=C2C=CC=CC2=C1N=NC1=NC=CS1 |
用途 |
NSC139021 (ERGi-USU) is a highly selective inhibitor of ERG-positive cancer cell growth, with IC50 values ranging from 30 to 400 nM across different cell lines; it shows minimal effect on normal prostate or endothelial cells and ERG-negative tumor cell lines; it exhibits additive growth-inhibitory effects when combined with enzalutamide in VCaP cells; it directly binds to the atypical kinase RIOK2, a regulator of ribosomal biogenesis, and induces a ribosomal stress signature; in vivo, it inhibits the growth of ERG-positive VCaP tumor xenografts without apparent toxicity, reducing tumor burden by 44% (100 mg/kg) and 65% (150 mg/kg). |
InChIKey |
IOMXCGDXEUDZAK-UHFFFAOYSA-N |
|
|
评论 |
|---|